LAMP1 and neoplasm: In addition to 51Cr release experiments, the killing of SKBR3 tumor cells was evidenced by their Annexin V+ 7-AAD− profile, while the state of iNKT cell activation was evaluated by CD107a expression, and secretion of TNFα and IFNγ (Fig. 4).